Healthcare & Pharmaceuticals Industry Press Releases

Published on June 4, 2023 - 22:00 GMT

Copywriting Services Announces new service to help Businesses Improve Online Presence with SEO-Optimised Web Content

BRISBANE, QUEENSLAND, AUSTRALIA, June 5, 2023 /⁨EINPresswire.com⁩/ -- Eddy Andrews Copywriting Services, a leading provider of professional content solutions, is delighted to introduce their new service designed to assist businesses in enhancing their …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...

Published on June 4, 2023 - 21:56 GMT

ALERCELL CELEBRATES NATIONAL CANCER SURVIVORS’ DAY® 2023

A celebration of LIfe BOZEMAN, MT, UNITED STATES, June 4, 2023 /⁨EINPresswire.com⁩/ -- Alercell celebrates today National Cancer Survivors’ Day. National Cancer Survivors’ Day Foundation invites all cancer survivors to celebrate this day and Alercell …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on June 4, 2023 - 18:20 GMT

IndyGeneUS Inks Development Partnership with US Army

A game-changing technology is underway for military and civilian first responders who may have had contact with dangerous materials. WASHINGTON, DC, UNITED STATES, June 4, 2023 /⁨EINPresswire.com⁩/ -- IndyGeneUS AI partners with The U.S. Army Combat …

Distribution channels: Chemical Industry, Emergency Services ...

Published on June 4, 2023 - 14:45 GMT

THE UNIVERSITY OF COLORADO CONCLUDES SEMAPHORIN 7A IN VIVO STUDY WITH GLOBAL CANCER TECHNOLOGY’S DRUG, GCT-007

THE LABORATORY OF DR. TRACI LYONS AT THE UNIVERSITY SHOWS THAT GCT-007 CAN SLOW SEMAPHORIN 7A-DEPENDENT TUMOR GROWTH IN PRECLINICAL MODELS OF BREAST CANCER SAN DIEGO, CALIFORNIA, UNITED STATES, June 4, 2023 /⁨EINPresswire.com⁩/ -- Global Cancer Technology …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on June 4, 2023 - 14:38 GMT

Championing Compliance and Patient to Effective Regenerative Therapies with Pharmaceutical Grade Exosomes

Supreme Rejuvenation emphasizes the significance of understanding the distinctions between 361 and 351a compliance, cGMP standards, third-party virology reports HOUSTON, TEXAS, USA, June 4, 2023 /⁨EINPresswire.com⁩/ -- Supreme Rejuvenation, a leading …

Distribution channels: Beauty & Hair Care, Business & Economy ...

Published on June 4, 2023 - 20:29 GMT

KI-Technologie von Evaxion identifiziert in klinischer Phase-I-Studie zu EVX-01 mit einem längeren progressionsfreien Überleben ...

Die klinische Studie zum personalisierten Krebsimpfstoff EVX-01 hat die primären Endpunkte der Sicherheit und Verträglichkeit erreicht Bei 8 von 12 mit EVX-01 behandelten Patienten wurden positive klinische Reaktionen festgestellt Hochwertige Neoantigene, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on June 4, 2023 - 20:29 GMT

La technologie d'IA d'Evaxion identifie des cibles de vaccin contre le cancer associées à une survie plus longue des patients sans ...

L'essai clinique du vaccin contre le cancer personnalisé EVX-01 satisfait à ses critères principaux d'innocuité et de tolérabilité Réponse clinique positive démontrée chez huit des douze patients traités avec l'EVX-01 Des néoantigènes de haute …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on June 4, 2023 - 16:45 GMT

Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or ...

Overall response rate (ORR) of 67% and clinical benefit rate (CBR) of 93% in 69 heavily pretreated RANO-HGG evaluable patients The Company expects to complete rolling NDA submission in October 2023 Conference call and webcast today at 6:00 p.m. CT BRISBANE …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on June 4, 2023 - 03:57 GMT

Worldipi.com Announces Groundbreaking Medical Technologies and Expands Business Operations for 2023

Intellectual Properties International Holdings, also known as Worldipi.com, shares its latest ventures in medical innovation and consumer products. PALM BEACH, FLORIDA, USA, June 3, 2023 /⁨EINPresswire.com⁩/ -- Intellectual Properties International …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on June 4, 2023 - 03:30 GMT

Calculator.io ने उद्योग मानक कैलोरी कैलकुलेटर का विमोचन किया

Calculator.io ने आहार और फिटनेस के लिए अपना नया उद्योग मानक कैलोरी कैलकुलेटर पेश किया है। LAS VEGAS, NEVADA, USA, June 4, 2023 /⁨EINPresswire.com⁩/ -- Calculator.io, एक मान्य डिजिटल प्लेटफॉर्म, अपने नवीनतम उपकरण के रूप में कैलोरी कैलकुलेटर का प्रकाशन करता …

Distribution channels: Beauty & Hair Care, Food & Beverage Industry ...

Published on June 4, 2023 - 02:30 GMT

Sanicle Hosts First Black Menstrual Health Summit 2023: Black Girls Matter

On May 26 and 27, 2023, the event took place at The Met Church in Tulsa, Oklahoma. TULSA, OKLAHOMA, UNITED STATES, June 3, 2023 /⁨EINPresswire.com⁩/ -- Sanicle.us, in collaboration with CF Industries, proudly hosted the groundbreaking 'Period Party,…

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 3, 2023 - 22:52 GMT

Inventor of Magnetic Tattoo Removal System Revealed as Pioneer in Tattoo Removal Industry

Linda Paradis is the visionary inventor behind the revolutionary Magnetic Tattoo Removal method. MIAMI, FLORIDA, USA, June 4, 2023 /⁨EINPresswire.com⁩/ -- The inventor of magnetic tattoo removal is Linda Paradis. She is a French-American aesthetician and …

Distribution channels: Beauty & Hair Care, Healthcare & Pharmaceuticals Industry ...

Published on June 3, 2023 - 16:05 GMT

The London Neurocognitive Clinic: Leading the way in supporting individuals with ASD

LONDON, LONDON, UNITED KINGDOM, June 3, 2023 /⁨EINPresswire.com⁩/ -- Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects how individuals perceive and interact with the world around them. It is characterised by persistent …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on June 3, 2023 - 14:33 GMT

Plastic Surgery Summit: Un evento que cambiará vidas

Fecha: 16 de junio, 6 PM, en el Graduate Center de Nueva York. Dirección: 365 5 th Ave, New York, NY 10016. NEW YORK, NEW YORK, UNITED STATES, June 3, 2023 /⁨EINPresswire.com⁩/ -- Plastic Surgery Summit: Un evento que cambiará vidas. Fecha: 16 de …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...

Published on June 3, 2023 - 14:16 GMT

Dr. Allen Foulad Achieves Natural Facelift and Neck Lift Results Using Advanced “Deep” Techniques

Dr. Allen Foulad based in Beverly Hills, is Hollywood’s new “go to” doctor his Achieves Natural Facelift and Neck Lift Results Using Advanced “Deep” Techniques BEVERLY HILLS, CA, USA, June 3, 2023 /⁨EINPresswire.com⁩/ -- Dr. Allen Foulad, a highly …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...

Published on June 3, 2023 - 21:00 GMT

Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in ...

The clinical trial of the personalized cancer vaccine EVX-01 met its primary endpoints of safety and tolerability Positive clinical responses were reported in 8 out of 12 EVX-01 treated patients High-quality neoantigens, predicted by AI technology, were …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on June 3, 2023 - 08:00 GMT

Dr. Zamip Patel honored with “Champion of Impact” Award by the “Kids Conquering Sickle Cell Disease Foundation”

Zamip Patel, M.D. received the Award for his health advocacy and support of patients with sickle cell disorders. ORLANDO, FLORIDA, USA, June 3, 2023 /⁨EINPresswire.com⁩/ -- At a Gala held in Orlando, Dr. Patel received the “Champion of Impact” award. The …

Distribution channels: Culture, Society & Lifestyle, Education ...

Published on June 3, 2023 - 20:00 GMT

Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion ...

- Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab tazevibulin, or luvelta, in ovarian cancer, demonstrating that FolRα-selected patients, who represent 80% of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on June 3, 2023 - 18:15 GMT

Cogent Biosciences Announces Positive Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with ...

- Data presented at ASCO annual meeting demonstrate 55% Disease Control Rate (DCR) in heavily pre-treated GIST patients, including 100% DCR and 17% overall response rate (ORR) in efficacy evaluable 2nd-line GIST patients; data immature to estimate …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on June 3, 2023 - 18:15 GMT

Replimune Presents RP1 Data from the IGNYTE anti-PD1 Failed Melanoma Cohort and RP2 Data in Uveal Melanoma at the 2023 American ...

Updated data from ongoing IGNYTE anti-PD1 failed melanoma cohort shows RP1 combined with nivolumab continues to demonstrate deep and durable responses with a well-tolerated safety profile; no progression in responding patients since the data snapshot …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire